- Home
- NVNO vs GCV Comparison
NVNO vs GCV Comparison
Compare NVNO & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- GCV
- Stock Information
- Founded
- NVNO 1987
- GCV 1988
- Country
- NVNO United States
- GCV United States
- Employees
- NVNO N/A
- GCV N/A
- Industry
- NVNO Medical/Dental Instruments
- GCV Finance/Investors Services
- Sector
- NVNO Health Care
- GCV Finance
- Exchange
- NVNO Nasdaq
- GCV Nasdaq
- Market Cap
- NVNO 78.7M
- GCV 76.3M
- IPO Year
- NVNO N/A
- GCV N/A
- Fundamental
- Price
- NVNO $4.05
- GCV $3.80
- Analyst Decision
- NVNO
- GCV
- Analyst Count
- NVNO 0
- GCV 0
- Target Price
- NVNO N/A
- GCV N/A
- AVG Volume (30 Days)
- NVNO 135.7K
- GCV 57.9K
- Earning Date
- NVNO 07-30-2025
- GCV 01-01-0001
- Dividend Yield
- NVNO N/A
- GCV 13.04%
- EPS Growth
- NVNO N/A
- GCV N/A
- EPS
- NVNO N/A
- GCV N/A
- Revenue
- NVNO N/A
- GCV N/A
- Revenue This Year
- NVNO N/A
- GCV N/A
- Revenue Next Year
- NVNO $409.09
- GCV N/A
- P/E Ratio
- NVNO N/A
- GCV N/A
- Revenue Growth
- NVNO N/A
- GCV N/A
- 52 Week Low
- NVNO $2.03
- GCV $3.15
- 52 Week High
- NVNO $6.48
- GCV $4.58
- Technical
- Relative Strength Index (RSI)
- NVNO 54.46
- GCV 59.07
- Support Level
- NVNO $4.19
- GCV $3.66
- Resistance Level
- NVNO $4.52
- GCV $3.75
- Average True Range (ATR)
- NVNO 0.39
- GCV 0.05
- MACD
- NVNO -0.01
- GCV -0.01
- Stochastic Oscillator
- NVNO 47.29
- GCV 71.05
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.